SRS Investment Management LLC Acquires Shares of 123,293 Humana Inc. (NYSE:HUM)

SRS Investment Management LLC purchased a new stake in shares of Humana Inc. (NYSE:HUM - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 123,293 shares of the insurance provider's stock, valued at approximately $31,281,000. Humana comprises about 0.4% of SRS Investment Management LLC's holdings, making the stock its 17th largest holding. SRS Investment Management LLC owned 0.10% of Humana at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in HUM. Virtu Financial LLC bought a new position in shares of Humana in the third quarter valued at approximately $631,000. Wilmington Savings Fund Society FSB purchased a new position in Humana during the third quarter valued at approximately $948,000. Tidal Investments LLC grew its stake in Humana by 38.4% during the third quarter. Tidal Investments LLC now owns 24,357 shares of the insurance provider's stock valued at $7,715,000 after acquiring an additional 6,755 shares in the last quarter. Synovus Financial Corp grew its stake in Humana by 4.1% during the third quarter. Synovus Financial Corp now owns 2,254 shares of the insurance provider's stock valued at $714,000 after acquiring an additional 89 shares in the last quarter. Finally, Oddo BHF Asset Management Sas purchased a new position in Humana during the third quarter valued at approximately $1,306,000. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Trading Down 1.5 %

Shares of HUM traded down $3.91 during mid-day trading on Friday, reaching $263.92. The company's stock had a trading volume of 1,097,942 shares, compared to its average volume of 1,747,221. The company's fifty day moving average price is $266.35 and its two-hundred day moving average price is $270.81. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $31.85 billion, a PE ratio of 26.52, a P/E/G ratio of 2.05 and a beta of 0.62.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a yield of 1.34%. Humana's dividend payout ratio is currently 35.58%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on HUM shares. Barclays boosted their price objective on shares of Humana from $270.00 to $322.00 and gave the company an "equal weight" rating in a research note on Friday, April 11th. Piper Sandler boosted their price objective on shares of Humana from $270.00 to $288.00 and gave the company a "neutral" rating in a research note on Wednesday, January 15th. Robert W. Baird boosted their price objective on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Guggenheim assumed coverage on shares of Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective for the company. Finally, Royal Bank of Canada reiterated an "outperform" rating and set a $283.00 target price on shares of Humana in a research report on Wednesday, February 12th. Seventeen equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, Humana currently has an average rating of "Hold" and an average target price of $284.90.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.